FDA's Califf Seeks His First Big Hire: Chief Scientist
The US agency seeks candidates for the executive position in charge of its research policy apparatus.
You may also be interested in...
Creation of agency's new Oncology Center of Excellence means the Office of Hematology and Oncology Products, often seen as FDA's model product review shop, needs new leadership – at least temporarily.
Device industry veteran John Sheets has been appointed as the new director of FDA's premarket review office for devices. It’s the second time this year that CDRH has tapped an industry executive to lead one of its offices.
Michael Taylor retires as deputy commissioner for foods and veterinary medicine on June 1 and will be succeeded by Stephen Ostroff, until recently FDA's acting commissioner and previously CFSAN's chief medical officer and senior public health advisor to Taylor.